Cargando…
Inhibition of Striatal Soluble Guanylyl Cyclase-cGMP Signaling Reverses Basal Ganglia Dysfunction and Akinesia in Experimental Parkinsonism
OBJECTIVE: There is clearly a necessity to identify novel non-dopaminergic mechanisms as new therapeutic targets for Parkinson's disease (PD). Among these, the soluble guanylyl cyclase (sGC)-cGMP signaling cascade is emerging as a promising candidate for second messenger-based therapies for the...
Autores principales: | Tseng, Kuei Y., Caballero, Adriana, Dec, Alexander, Cass, Daryn K., Simak, Natalie, Sunu, Elizabeth, Park, Michael J., Blume, Shannon R., Sammut, Stephen, Park, Diana J., West, Anthony R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206945/ https://www.ncbi.nlm.nih.gov/pubmed/22073284 http://dx.doi.org/10.1371/journal.pone.0027187 |
Ejemplares similares
-
Signaling via guanylyl cyclase C: cGMP, Src and p21
por: Basu, Nirmalya, et al.
Publicado: (2011) -
Particulate Guanylyl Cyclase A/cGMP Signaling Pathway in the Kidney: Physiologic and Therapeutic Indications
por: Chen, Yang, et al.
Publicado: (2018) -
Homogeneous single-label cGMP detection platform for the functional study of nitric oxide-sensitive (soluble) guanylyl cyclases and cGMP-specific phosphodiesterases
por: Kopra, Kari, et al.
Publicado: (2020) -
Subcellular trafficking of guanylyl cyclase/natriuretic peptide receptor-A with concurrent generation of intracellular cGMP
por: Mani, Indra, et al.
Publicado: (2015) -
Stimulation of Erythrocyte Soluble Guanylyl Cyclase Induces cGMP Export and Cardioprotection in Type 2 Diabetes
por: Jiao, Tong, et al.
Publicado: (2023)